Perfect Medical (01830) announced that on April 28, 2026, the board of directors proposed the adoption of a new share option scheme (the 2026 Share Option Scheme) and the termination of the company's existing share option scheme, subject to approval by the company's shareholders. On the same date, the board proposed conditionally granting 50 million share options under the 2026 Share Option Scheme to Dr. Ouyang Jiang, who serves as the company's chairman, chief executive officer, executive director, and controlling shareholder. These options will grant the recipient the right to subscribe for a total of 50 million new shares, representing approximately 3.98% of the issued share capital (excluding treasury shares) as of the date of this announcement.